CLINICAL ROLE -
Biosimilars: Could This Be a Pearl in the Patient Protection and Affordable Care Act?
Introducing Specialty Pharmacy Times: Seizing the Moment
Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
The Special Definition of Average Manufacturer Price
Optimism and Opportunity
Near-Term Specialty Pipeline Highlights October 2010
CSL Behring's Privigen
Life in a Specialty Pharmacy
Upcoming Fall/Winter Meetings
What Will Drive the Specialty Pharmacy Models of Tomorrow?
Current Trends in IG Therapy
Navigating the Perils of Fair Market Value
Continuing Education for the Specialty Pharmacist
Rheumatoid Arthritis Watch
Oncology Watch
Multiple Sclerosis Watch
